Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
a Department of Epidemiology and Biostatistics, Institute of Child Health, London WC1N 1EH, b Medical Eye Unit, St Thomas's Hospital, London SE1 7EH, c Department of Ophthalmology, St George's Hospital, London SW17 0QT, d Public Health Laboratory Service Toxoplasma Reference Unit, St George's Hospital, London SW17 0QT
Correspondence to: Dr Gilbert.
Abstract
Objective: To determine the incidence of acute symptomatic toxoplasma retinochoroiditis presenting to ophthalmologists for patients born in Britain and elsewhere.
Design: Population based, cross sectional study.
Setting: 11 districts in south Greater London.
Subjects: All patients presenting to NHS ophthalmologists with symptoms due to acute toxoplasma retinochoroiditis in 1992-3.
Main outcome measure: Intraocular inflammation in association with a retinochoroidal scar, active adjoining retinitis, and IgG serum antibodies to toxoplasma.
Results: The estimated incidence of acute symptomatic retinochoroiditis for all people born in Britain was 0.4/100 000/year and for black people born in west Africa 57/100 000/year. If a mean of two symptomatic episodes per lifetime is assumed, 100 people born in Britain may be affected each year, about a fifth of the estimated 500-600 congenitally infected people born each year.
Conclusions: A substantial proportion of people with acute symptomatic toxoplasma retinochoroiditis were born outside the country, and the number born in Britain was smaller than the number previously estimated to develop retinochoroidal lesions due to congenital toxoplasmosis. These findings suggest that prenatal screening for toxoplasmosis in Britain may be of limited benefit.
|
Key messages
|
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?